The 20 Year Journey to Denali’s First Drug Approval | Dr. Ryan Watts

What does it take to spend decades pursuing one of the hardest problems in medicine?
In this episode of HiveCast, Jared Bauer sits down with Dr. Ryan Watts, CEO of Denali Therapeutics.
Ryan shares why he chose neurodegenerative disease as the problem he wanted to dedicate his career to solving despite the enormous challenges and high failure rates in the field.
He also reflects on the emotional day Denali received approval for its first drug after nearly 20 years of work and discusses the extraordinary effort from the team that helped make it possible. 
 

In Partnership with University of Utah Health Plans

🎧 Listen on SpotifyApple Podcasts and Youtube
📺 Subscribe for more conversations with leaders in biotech, healthcare and life sciences innovation.